Cargando…
Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999272/ https://www.ncbi.nlm.nih.gov/pubmed/24790414 http://dx.doi.org/10.2147/PPA.S63080 |
| _version_ | 1782313479463501824 |
|---|---|
| author | Doggrell, Sheila A |
| author_facet | Doggrell, Sheila A |
| author_sort | Doggrell, Sheila A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3999272 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39992722014-04-30 Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin Doggrell, Sheila A Patient Prefer Adherence Letter Dove Medical Press 2014-04-15 /pmc/articles/PMC3999272/ /pubmed/24790414 http://dx.doi.org/10.2147/PPA.S63080 Text en © 2014 Doggrell. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed |
| spellingShingle | Letter Doggrell, Sheila A Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin |
| title | Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin |
| title_full | Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin |
| title_fullStr | Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin |
| title_full_unstemmed | Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin |
| title_short | Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin |
| title_sort | clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999272/ https://www.ncbi.nlm.nih.gov/pubmed/24790414 http://dx.doi.org/10.2147/PPA.S63080 |
| work_keys_str_mv | AT doggrellsheilaa clinicaloutcomesnotclinicalutilityshouldbethemajorconsiderationforsaxagliptinwithorwithoutmetformin |